Antiangiogenic combination therapy after local radiotherapy with topotecan radiosensitizer improved quality of life for children with inoperable brainstem gliomas

Acta Paediatrica, International Journal of Paediatrics

Volumn 100, Issue 1, 2011, Pages 134-138

  Kivivuori, Sanna Maria ^a   Riikonen, Pekka ^b   Valanne, Leena ^a   Lönnqvist, Tuula ^a   Saarinen Pihkala, Ulla M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; ETOPOSIDE; RADIOSENSITIZING AGENT; THALIDOMIDE; TOPOTECAN;

ADOLESCENT; ANTIANGIOGENIC THERAPY; ARTICLE; BRAIN STEM GLIOMA; CANCER RADIOTHERAPY; CHILD; CLINICAL TRIAL; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; SCHOOL CHILD; SURVIVAL RATE; TUMOR VOLUME;

ADOLESCENT; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN STEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ETOPOSIDE; GLIOMA; HUMANS; PILOT PROJECTS; PYRAZOLES; QUALITY OF LIFE; RADIATION-SENSITIZING AGENTS; SULFONAMIDES; SURVIVAL ANALYSIS; THALIDOMIDE; TOPOTECAN; TREATMENT OUTCOME;

EID: 78650140705     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.01961.x     Document Type: Article

References (14)

1. Finlay JL, Zacharoulis S,. The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical-and futuristic-perspective. J Neurooncol 2005; 75: 253-66.
2. Takano S, Kamiyama H, Tsuboi K, Matsumura A,. Angiogenesis and antiangiogenic therapy for malignant gliomas. Brain Tumor Pathol 2004; 21: 69-73.
3. Jensen RL,. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. Surg Neurol 1998; 49: 189-95; discussion 196.
4. D'Amato RJ, Loughnan MS, Flynn E, Folkman J,. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A 1994; 91: 4082-5.
5. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000; 60: 1306-11.
6. Drevs J, Fakler J, Eisele S, Medinger M, Bing G, Esser N, et al. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. Anticancer Res 2004; 24: 1759-63.
7. Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O'Reilly MS, et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000; 60: 1878-86.
8. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-16.
9. Mauffrey C,. Paediatric brainstem gliomas: prognostic factors and management. J Clin Neurosci 2006; 13: 431-7.
10. Sanghavi SN, Needle MN, Krailo MD, Geyer JR, Ater J, Mehta MP,. A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952. Neuro Oncol 2003; 5: 8-13.
11. Bernier-Chastagner V, Grill J, Doz F, Bracard S, Gentet JC, Marie-Cardine A, et al. Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Cancer 2005; 104: 2792-7.
12. Lopez-Aguilar E, Sepulveda-Vildosola AC, Betanzos-Cabrera Y, Rocha-Moreno YG, Gascon-Lastiri G, Rivera-Marquez H, et al. Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children. Arch Med Res 2008; 39: 655-62.
13. Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Poussaint TY, et al. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. J Neurooncol 2007; 82: 95-101.
14. Kerbel RS,. Tumor angiogenesis. N Engl J Med 2008; 358: 2039-49.